Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4659683)

Published in PLoS One on November 25, 2015

Authors

Zhen Sheng1, Yi Sun1, Ruixin Zhu1, Na Jiao1, Kailin Tang1, Zhiwei Cao1, Chao Ma1,2

Author Affiliations

1: School of Life Science and Technology, Tongji University, Shanghai, People's Republic of China.
2: Key Lab of Systems Biology, Shanghai Institutes for Biological Science, Chinese Academy of Science, Shanghai, People's Republic of China.

Articles cited by this

DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79

Differential expression analysis for sequence count data. Genome Biol (2010) 64.56

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol (2013) 32.42

HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics (2014) 23.22

Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res (2013) 15.13

DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics (2009) 14.83

Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol (2012) 14.01

The Gene Ontology project in 2008. Nucleic Acids Res (2007) 11.71

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (1999) 10.48

Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods (2010) 10.13

Nova regulates brain-specific splicing to shape the synapse. Nat Genet (2005) 6.58

Detecting differential usage of exons from RNA-seq data. Genome Res (2012) 6.34

A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev (1999) 6.34

Function of alternative splicing. Gene (2004) 5.95

A new method to measure the semantic similarity of GO terms. Bioinformatics (2007) 5.91

Structure of an IkappaBalpha/NF-kappaB complex. Cell (1998) 5.67

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev (1994) 4.64

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol (2008) 3.41

GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics (2010) 3.20

Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci U S A (2001) 3.16

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59

AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res (2010) 2.41

PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev (2000) 2.33

High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer (2009) 2.03

p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell (2005) 1.46

Berberine: new perspectives for old remedies. Biochem Pharmacol (2012) 1.45

Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res (2003) 1.41

Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol (2010) 1.39

Functional coupling of last-intron splicing and 3'-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage. Mol Cell Biol (2007) 1.33

Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs. Mol Cancer (2009) 1.31

p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ (2006) 1.30

DiffSplice: the genome-wide detection of differential splicing events with RNA-seq. Nucleic Acids Res (2012) 1.28

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat (2006) 1.13

Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. Mol Cancer Ther (2008) 1.08

SplicingCompass: differential splicing detection using RNA-seq data. Bioinformatics (2013) 1.07

Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis. Anticancer Res (2009) 1.07

Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res (2008) 1.04

Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions. Nucleic Acids Res (2008) 1.03

Berberine. Altern Med Rev (2000) 1.02

Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int J Oncol (2009) 1.02

Transcriptional control by NF-κB: elongation in focus. Biochim Biophys Acta (2013) 0.98

Berberine, an epiphany against cancer. Molecules (2014) 0.95

Functional coupling of transcription and splicing. Gene (2012) 0.95

IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle (2010) 0.94

A survey of software for genome-wide discovery of differential splicing in RNA-Seq data. Hum Genomics (2014) 0.92

Gene expression profiles of hepatoma cell line BEL-7402. Hepatogastroenterology (2003) 0.91

Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinoma. Mol Med Rep (2013) 0.87

Alternative splicing for diseases, cancers, drugs, and databases. ScientificWorldJournal (2013) 0.82

Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells. Chem Biol Drug Des (2013) 0.82

A recently evolved class of alternative 3'-terminal exons involved in cell cycle regulation by topoisomerase inhibitors. Nat Commun (2014) 0.78

Postprandial activation of p53-dependent DNA repair is modified by Mediterranean diet supplemented with coenzyme Q10 in elderly subjects. J Gerontol A Biol Sci Med Sci (2013) 0.77

Adenovirus-mediated p53 gene therapy in nasopharyngeal cancer. Int J Oncol (1997) 0.76